Loading: 100%
Profit & Loss StatementP&L data quality: 0% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reasons:
- It is not known how cost items are reported in the original P&L
- Not all line items from the original statement have been associated with a standardised figure (16 items missing)
No data available for the selected time periods
in million USD FY '10FY '11FY '12FY '13FY '14FY '15FY '16
License and milestone fees
6
6
9
24
39
58
27
Royalty revenue
0
0
0
1
10
14
0
Non-cash royalty revenue related to sale of future royalties
0
0
0
0
0
5
25
Research and development support
5
7
5
8
7
3
4
Clinical materials revenue
3
6
3
3
3
6
4
Total revenues
14
19
16
36
60
86
60
Research and development
50
63
69
87
107
112
148
General and administrative
15
16
20
21
24
28
37
Total operating expenses
65
79
90
109
131
140
185
(Loss) income from operations
-51
-60
-73
-73
-72
-54
-125
Investment income, net
0
0
0
0
0
0
0
Non-cash interest expense on liability related to the sale of future royalties
0
0
0
0
0
-5
-20
Other (expense) income, net
0
2
0
0
0
-1
0
Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Extraordinary Items, Noncontrolling Interest
-51
0
0
0
0
0
0
Income tax expense (benefit)
0
0
0
0
0
0
0
Net (loss) income
-51
-58
-73
-73
-71
-61
-145
Remarks
restated on Nov 30, -1 n/a
calculated values,
restated on Nov 30, -1 n/a
calculated values,
restated on Aug 28, 2014 n/a
calculated values,
restated on Nov 30, -1 n/a
calculated values,
restated on Nov 30, -1 n/a
calculated values,
restated on Aug 25, 2016 n/a
calculated values,
restated on Nov 30, -1 n/a
calculated values,
Balance SheetBS data quality: 0% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
- Not all line items from the original statement have been associated with a standardised figure (33 items missing)
No data available for the selected time periods
in million USD FY '10FY '11FY '12FY '13FY '14FY '15FY '16
Assets
Cash and cash equivalents
n/a
191
161
195
142
278
245
Accounts receivable
n/a
5
0
0
2
5
1
Unbilled revenue
n/a
1
1
2
1
1
1
Inventory
n/a
0
1
1
3
3
1
Restricted cash
n/a
1
0
0
0
0
0
Current portion of deferred financing costs
n/a
0
0
0
0
1
2
Prepaid and other current assets
n/a
3
2
3
2
4
5
Total current assets
n/a
202
166
201
151
292
255
Property and equipment, net of accumulated depreciation
n/a
13
12
11
14
16
23
Long-term restricted cash
n/a
3
2
2
0
0
0
Deferred financing costs, net of current portion
n/a
0
0
0
0
4
6
Other assets
n/a
0
0
0
0
1
3
Total assets
n/a
218
180
214
165
314
287
Liabilities and owners' equity
Accounts payable
n/a
3 3213000
3 3395000
4 4498000
5 4819000
8 8138000
12 11510000
Accrued compensation
n/a
5 4723000
5 4942000
6 6153000
7 6865000
8 8346000
11 10724000
Other accrued liabilities
n/a
3 3305000
5 4589000
6 6049000
7 6668000
10 10441000
10 9713000
Current portion of deferred lease incentive
n/a
1 979000
1 979000
1 979000
1 528000
1 646000
1 772000
Current portion of liability related to the sale of future royalties
n/a
0 0
0 0
0 0
0 0
8 7906000
15 15138000
Current portion of deferred revenue
n/a
2 2346000
2 2349000
1 1494000
2 2374000
0 333000
14 13582000
Total current liabilities
n/a
15 14566000
16 16254000
19 19173000
21 21254000
36 35810000
61 61439000
Deferred lease incentive, net of current portion
n/a
8 7583000
7 6605000
6 5626000
6 5679000
6 6301000
6 6236000
Deferred revenue, net of current portion
n/a
52 51545000
70 69761000
63 63384000
59 58969000
41 40855000
19 19288000
Liability related to the sale of future royalties, net of current portion
n/a
0 0
0 0
0 0
0 0
192 191756000
178 178234000
Convertible 4.5% senior notes
n/a
0 0
0 0
0 0
0 0
0 0
100 100000000
Other long-term liabilities
n/a
4 3978000
4 3798000
4 3566000
4 3717000
4 3997000
4 4192000
Total liabilities
n/a
78 77672000
96 96418000
92 91749000
90 89619000
279 278719000
369 369389000
Commitments and contingencies (Note H)
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Preferred stock, $0.01 par value; authorized 5,000 shares; no shares issued and outstanding
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Common stock, $.01 par value; authorized 150,000 shares; issued and outstanding 86,579 and 85,903 shares as of June 30, 2015 and 2014, respectively
n/a
1 763000
1 778000
1 847000
1 859000
1 866000
1 872000
Additional paid-in capital
n/a
570 569843000
587 587068000
698 697767000
723 722971000
743 743108000
771 770511000
Accumulated deficit
n/a
-431 -430637000
-504 -503956000
-577 -576767000
-648 -648131000
-709 -708870000
-854 -853687000
Total shareholders' equity
n/a
140 139969000
84 83890000
122 121847000
76 75699000
35 35104000
-82 -82304000
Total liabilities and shareholders' equity
n/a
218 217641000
180 180308000
214 213596000
165 165318000
314 313823000
287 287085000
Remarks restated on n/a restated on Nov 30, -1 n/a restated on Nov 30, -1 n/a restated on Nov 30, -1 n/a restated on Nov 30, -1 n/a restated on Nov 30, -1 n/a restated on Nov 30, -1 n/a
Cash Flow StatementCF data quality: 0% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
- Not all line items from the original statement have been associated with a standardised figure (34 items missing)
No data available for the selected time periods
in million USD FY '10FY '11FY '12FY '13FY '14FY '15FY '16
Net loss
-51
-58
-73
-73
-71
-61
-145
Non-cash royalty revenue related to sale of future royalties
0
0
0
0
0
-5
-25
Non-cash interest expense on liability related to sale of future royalties
0
0
0
0
0
5
20
Depreciation and amortization
5
5
5
5
5
6
5
Loss (Gain) on sale/disposal of fixed assets
0
0
0
0
0
0
0
This element represents the amortization of the deferred lease incentive received by the lessee and amortized over the term of the lease.
-1
0
0
0
0
0
0
Marketable Securities, Gain (Loss)
0
0
0
0
0
0
0
Gain on forward contracts
0
0
0
0
0
0
0
Non-cash licensing fee
0
0
0
0
13
0
0
Stock and deferred share unit compensation
5
6
10
13
16
16
22
Deferred rent
0
0
0
0
0
0
0
Accounts receivable
0
-3
5
0
-2
-3
4
Unbilled revenue
-1
0
0
-1
1
1
-1
Inventory
1
1
-1
1
-2
0
2
Prepaid and other current assets
0
-1
0
0
1
-2
-1
Restricted cash
0
1
1
0
2
0
0
Other assets
0
0
0
0
0
-1
-2
Accounts payable
2
0
0
1
0
3
3
Accrued compensation
0
1
0
1
1
1
2
Other accrued liabilities
1
0
0
0
0
3
-1
Deferred revenue, net of non-cash upfront license payment
-1
42
18
-7
-17
-20
-8
Proceeds from landlord for tenant improvements
0
0
0
0
0
1
0
Net Cash Used For Operating Activities
-41
-8
-34
-60
-54
-55
-124
Proceeds from Sale and Maturity of Marketable Securities
1
1
0
0
0
0
0
Purchases of property and equipment, net
-2
-2
-3
-4
-8
-7
-10
(Payments) proceeds from settlement of forward contracts
0
0
0
0
0
0
0
Net cash used for investing activities
-1
-1
-3
-4
-8
-7
-10
Proceeds from stock options exercised
3
3
7
4
9
4
5
Proceeds from sale of future royalties, net of $5,865 of transaction costs
0
0
0
0
0
194
0
Proceeds from issuance of convertible 4.5% notes, net of $3,392 of transaction costs
0
0
0
0
0
0
97
Proceeds from common stock issuance, net
78
88
0
94
0
0
0
Net cash provided by financing activities
81
91
7
98
9
199
102
Net change in cash and cash equivalents
40
82
-30
34
-53
136
-33
Remarks
restated on Nov 30, -1 n/a
calculated values,
restated on Nov 30, -1 n/a
calculated values,
restated on Aug 28, 2014 n/a
calculated values,
restated on Nov 30, -1 n/a
calculated values,
restated on Aug 25, 2016 n/a
calculated values,
restated on Aug 25, 2016 n/a
calculated values,
restated on Nov 30, -1 n/a
calculated values,